Exane Derivatives’s Comerica CMA Stock Holding History

Exane Derivatives’s Portfolio CMA Stock Details CMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$96K	Sell	1,309 -205	-14%	-$16.6K	0.06%	268
2022 Q1	$137K	Sell	1,514 -13	-0.9%	-$1.23K	0.04%	422
2021 Q4	$133K	Sell	1,527 -902	-37%	-$77.4K	0.03%	409
2021 Q3	$196K	Buy	2,429 +428	+21%	+$30.8K	0.05%	397
2021 Q2	$138K	Buy	2,001 +959	+92%	+$71.1K	0.03%	501
2021 Q1	$74.8K	Buy	+1,042	New	+$68.2K	0.02%	463
2019 Q2	–	Sell	-1,979	Closed	-$145K	–	672
2019 Q1	$145K	Sell	1,979 -430	-18%	-$34.5K	0.03%	262
2018 Q4	$165K	Hold	2,409	–	–	0.03%	270
2018 Q3	$218K	Sell	2,409 -63	-3%	-$6.01K	0.04%	236
2018 Q2	$229K	Sell	2,472 -619	-20%	-$59.3K	0.04%	250
2018 Q1	$291K	Buy	3,091 +70	+2%	+$6.67K	0.06%	208
2017 Q4	$262K	Buy	3,021 +1,334	+79%	+$107K	0.05%	218
2017 Q3	$129K	Sell	1,687 -17	-1%	-$1.22K	0.02%	230
2017 Q2	$125K	Buy	+1,704	New	+$120K	0.03%	251

Other funds holding CMA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Exane Derivatives's CMA Position: Q2 2022 in Review

Exane Derivatives reduced its Comerica (CMA) stake by 14% in Q2 2022, selling an estimated $16.6K and leaving 1,309 shares worth $96K. The position accounts for 0.06% of the portfolio, ranked #268.

Exane Derivatives first reported a position in CMA in Q2 2017 and has held it in 14 quarters since. The position peaked at $291K in Q1 2018. 569 funds tracked by Wall St. Rank hold CMA as of Q2 2022.

Exane Derivatives held 1,309 shares of Comerica worth $96K as of Q2 2022.
Exane Derivatives sold 205 Comerica shares in Q2 2022, an estimated $16.6K.
Comerica made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #268 holding.
Exane Derivatives first reported a position in Comerica in Q2 2017 and has held it in 14 quarters since.
Exane Derivatives's Comerica position peaked at $291K in Q1 2018.
569 funds tracked by Wall St. Rank held Comerica as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.